References
Wöhrer S, Troch M, Streubel B, Hoffmann M, Müllauer L, Chott A et al (2007) Pathology and clinical course of MALT lymphoma with plasmacytic differentiation. Ann Oncol 18(12):2020–2024
Cohen SM, Petryk M, Varma M, Kozuch PS, Ames ED, Grossbard ML (2006) Non-Hodgkin’s lymphoma of mucosa-associated lymphoid tissue. Lymphoma Oncol Oncol 1111:1100–1117
Tsukamoto A, Nakamura F, Nannya Y, Kobayashi Y, Shibahara J, Ichikawa M, Fukayama M, Koike K, Kurokawa M (2014) MALT lymphoma of the small bowel with protein-losing enteropathy. Int J Hematol 99:198–201
Nakamura F, Nakamura F, Ikemura M, Fukayama M, Kurokawa M (2016) Extraosseous plasmacytoma in the nasal cavity after rituximab therapy against pulmonary MALT lymphoma. Ann Hematol 95:1733–1735
Woehrer S, Streubel B, Chott A, Hoffmann M, Raderer M (2005) Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab. Leuk Lymphoma 46(11):1645–1649
Klein N, Elis A, Radnay J, Zemer R, Klein A, Lishner M (2009) Transformation of MALT lymphoma to pure plasma cell histology: possible association with anti-CD20 antibody treatment. Isr Med Assoc J 11:703–704
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Written informed consent was obtained from the patient.
Rights and permissions
About this article
Cite this article
Suzuki, Y., Honda, A., Nakazaki, K. et al. Histological transformation of MALT lymphoma to plasma cell leukemia after rituximab-containing therapy. Ann Hematol 97, 1297–1298 (2018). https://doi.org/10.1007/s00277-018-3300-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-018-3300-2